Loading…

Modulation of adenosine receptor affinity and intrinsic efficacy in adenine nucleosides substituted at the 2-position

We have studied the structural determinants of binding affinity and efficacy of adenosine receptor (AR) agonists. Substituents at the 2-position of adenosine have been combined with N 6-substitutions known to enhance human A 3AR affinity. The environment surrounding the 2-position within the putativ...

Full description

Saved in:
Bibliographic Details
Published in:Bioorganic & medicinal chemistry 2004-06, Vol.12 (11), p.2995-3007
Main Authors: Ohno, Michihiro, Gao, Zhan-Guo, Van Rompaey, Philippe, Tchilibon, Susanna, Kim, Soo-Kyung, Harris, Brian A, Gross, Ariel S, Duong, Heng T, Van Calenbergh, Serge, Jacobson, Kenneth A
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We have studied the structural determinants of binding affinity and efficacy of adenosine receptor (AR) agonists. Substituents at the 2-position of adenosine have been combined with N 6-substitutions known to enhance human A 3AR affinity. The environment surrounding the 2-position within the putative A 3AR binding site was explored using rhodopsin-based homology modeling and ligand docking. We studied the structural determinants of binding affinity and efficacy of adenosine receptor (AR) agonists. Substituents at the 2-position of adenosine were combined with N 6-substitutions known to enhance human A 3AR affinity. Selectivity of binding of the analogues and their functional effects on cAMP production were studied using recombinant human A 1, A 2A, A 2B, and A 3ARs. Mainly sterically small substituents at the 2-position modulated both the affinity and intrinsic efficacy at all subtypes. The 2-cyano group decreased hA 3AR affinity and efficacy in the cases of N 6-(3-iodobenzyl) and N 6-( trans-2-phenyl-1-cyclopropyl), for which a full A 3AR agonist was converted into a selective antagonist; the 2-cyano- N 6-methyl analogue was a full A 3AR agonist. The combination of N 6-benzyl and various 2-substitutions (chloro, trifluoromethyl, and cyano) resulted in reduced efficacy at the A 1AR. The environment surrounding the 2-position within the putative A 3AR binding site was explored using rhodopsin-based homology modeling and ligand docking.
ISSN:0968-0896
1464-3391
DOI:10.1016/j.bmc.2004.03.031